NO993341L - Analoger av paratyroidhormon - Google Patents

Analoger av paratyroidhormon

Info

Publication number
NO993341L
NO993341L NO993341A NO993341A NO993341L NO 993341 L NO993341 L NO 993341L NO 993341 A NO993341 A NO 993341A NO 993341 A NO993341 A NO 993341A NO 993341 L NO993341 L NO 993341L
Authority
NO
Norway
Prior art keywords
parathyroid hormone
analogues
pthrp
pth
acc
Prior art date
Application number
NO993341A
Other languages
English (en)
Norwegian (no)
Other versions
NO993341D0 (no
Inventor
Zheng Xin Dong
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Publication of NO993341D0 publication Critical patent/NO993341D0/no
Publication of NO993341L publication Critical patent/NO993341L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO993341A 1997-01-07 1999-07-06 Analoger av paratyroidhormon NO993341L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone
PCT/US1997/022498 WO1998030590A2 (en) 1997-01-07 1997-12-08 Analogs of parathyroid hormone

Publications (2)

Publication Number Publication Date
NO993341D0 NO993341D0 (no) 1999-07-06
NO993341L true NO993341L (no) 1999-09-06

Family

ID=27119618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993341A NO993341L (no) 1997-01-07 1999-07-06 Analoger av paratyroidhormon

Country Status (23)

Country Link
US (1) US5955574A (de)
EP (3) EP1645566B1 (de)
JP (1) JP3963482B2 (de)
KR (2) KR100699422B1 (de)
CN (1) CN1137898C (de)
AR (3) AR011517A1 (de)
AT (2) ATE321784T1 (de)
AU (1) AU741584B2 (de)
BR (1) BR9714200A (de)
CA (1) CA2276614C (de)
CZ (2) CZ298937B6 (de)
DE (2) DE69735603T2 (de)
DK (2) DK0948541T3 (de)
ES (2) ES2258286T3 (de)
HU (1) HUP9904596A3 (de)
IL (1) IL130794A0 (de)
NO (1) NO993341L (de)
NZ (1) NZ336610A (de)
PL (1) PL191898B1 (de)
PT (2) PT948541E (de)
RU (1) RU2198182C2 (de)
SI (2) SI0948541T1 (de)
WO (1) WO1998030590A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544949B1 (en) 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
AU752925B2 (en) * 1997-09-09 2002-10-03 F. Hoffmann-La Roche Ag Fracture healing using PTHrP analogs
HUP0300891A2 (hu) * 1998-05-05 2003-07-28 Beth Israel Deaconess Medical Center, Inc. PTH2 receptor szelektív vegyületek és alkalmazásuk gyógyszerkészítmények előállÍtására
CA2335341A1 (en) * 1998-07-20 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Peptide analogues of pacap
US6660843B1 (en) † 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
EP1257576B1 (de) * 2000-02-18 2004-09-15 Dabur Research Foundation Vip-analoge
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
CA2446929C (en) * 2001-06-01 2013-04-09 Novartis Ag Orally administering parathyroid hormone and calcitonin
AU2002339843B2 (en) 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
EP1651246A4 (de) * 2003-08-06 2009-06-24 Innophos Inc Verfahren zur förderung des knochenwachstums
CN101355959B (zh) 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
EP2073789B8 (de) * 2006-10-03 2023-02-08 Radius Health, Inc. Stabile zusammensetzung mit anabolischem knochenprotein, und zwar einem pthrp-analogon, sowie deren verwendung
ATE469173T1 (de) * 2006-10-13 2010-06-15 Lilly Co Eli Pegyliertes pth als pth-rezeptormodulatoren und ihre verwendung
MX353986B (es) 2007-08-01 2017-11-06 Massachusetts Gen Hospital Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas.
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
CA2782640A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
SI2568806T1 (sl) 2010-05-12 2016-09-30 Radius Health, Inc. Režimi zdravljenja
JP5941040B2 (ja) 2010-05-13 2016-06-29 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン類似体およびその使用
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
EP4035664A3 (de) 2014-03-28 2022-11-30 Duke University Behandlung von krebs unter verwendung von selektiven östrogenrezeptormodulatoren
MX393599B (es) 2015-04-29 2025-03-19 Radius Pharmaceuticals Inc Rad1901 para usarse en el tratamiento de cancer en sujetos con cancer positivo a receptor de estrogeno alfa resistente a farmaco
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
RU2769527C2 (ru) 2016-06-22 2022-04-01 Эллипсес Фарма Лтд Способы лечения ar+ рака молочной железы
DK3565542T3 (da) 2017-01-05 2024-07-01 Radius Pharmaceuticals Inc Polymorphic forms of rad1901-2hcl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
KR102792490B1 (ko) 2018-07-04 2025-04-04 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
MX2021009569A (es) 2019-02-12 2021-09-08 Radius Pharmaceuticals Inc Procesos y compuestos.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (de) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroide Hormon-Antagonisten
US5457047A (en) * 1989-02-23 1995-10-10 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
AU2807892A (en) * 1991-10-10 1993-05-03 Peter K.T. Pang Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
EP0678018B1 (de) 1993-01-06 2003-04-09 Kinerton Limited Ionische molekularkonjugate von bioabbaubaren polyestern und bioaktiven polypeptiden
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽：合成和治疗骨质疏松症的用途
WO1996019246A1 (en) * 1994-12-19 1996-06-27 Beth Israel Hospital Association Continuous low-dose administration of parathyroid hormone or its agonist
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
WO1998030590A2 (en) 1998-07-16
CZ239899A3 (cs) 2000-01-12
EP0948541A2 (de) 1999-10-13
JP3963482B2 (ja) 2007-08-22
SI1645566T1 (sl) 2010-11-30
KR100497709B1 (ko) 2005-06-23
CN1137898C (zh) 2004-02-11
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
CZ301497B6 (cs) 2010-03-24
AU741584B2 (en) 2001-12-06
CN1254347A (zh) 2000-05-24
SI0948541T1 (sl) 2006-06-30
AR011517A1 (es) 2000-08-30
AU5519998A (en) 1998-08-03
US5955574A (en) 1999-09-21
PT1645566E (pt) 2010-08-31
CZ298937B6 (cs) 2008-03-19
DE69735603D1 (de) 2006-05-18
WO1998030590A3 (en) 1998-12-10
EP0948541B1 (de) 2006-03-29
CA2276614C (en) 2002-06-11
AR051906A2 (es) 2007-02-14
EP1645566A3 (de) 2006-10-11
EP1645566B1 (de) 2010-06-16
ES2347154T3 (es) 2010-10-26
DE69739912D1 (de) 2010-07-29
HK1026215A1 (en) 2000-12-08
KR100699422B1 (ko) 2007-03-28
EP2206725A1 (de) 2010-07-14
DK1645566T3 (da) 2010-09-27
HUP9904596A3 (en) 2000-07-28
CA2276614A1 (en) 1998-07-16
HUP9904596A1 (hu) 2000-06-28
IL130794A0 (en) 2001-01-28
RU2198182C2 (ru) 2003-02-10
AR038552A2 (es) 2005-01-19
KR20060030006A (ko) 2006-04-07
PT948541E (pt) 2006-07-31
NZ336610A (en) 2001-07-27
KR20000069952A (ko) 2000-11-25
ES2258286T3 (es) 2006-08-16
ATE471342T1 (de) 2010-07-15
WO1998030590A9 (en) 1999-08-19
DK0948541T3 (da) 2006-07-17
BR9714200A (pt) 2000-03-28
DE69735603T2 (de) 2006-11-30
ATE321784T1 (de) 2006-04-15
PL334438A1 (en) 2000-02-28
JP2001508439A (ja) 2001-06-26
EP1645566A2 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
NO993341L (no) Analoger av paratyroidhormon
EA199901025A1 (ru) Пептидные аналоги паратиреоидного гормона
ATE354584T1 (de) Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
ATE304020T1 (de) Parathyroidhormon-verwandthe peptidanaloge
NZ527053A (en) Modified amyloid precursor protein polynucleotides and polypeptides
IL210454A (en) Antibody against a new ligand of cytokine 17zcytor
DE69638025D1 (de) Parathyroidhormon Analoge
EA200001071A1 (ru) Способ получения полимер-связанных циклических пептидов
EP0293159A3 (de) Parathyroid-Hormon-Antagonisten mit vereinfachter synthetischer Methodologie
EP0293158A3 (de) Parathyroide Hormon-Antagonisten
AP2000001888A0 (en) Method for treatment of diabetes using peptides analogues of insulin.
HUP9701277A2 (hu) Eljárás parathiroid hormon és parathiroid hormonnal rokon peptidek analógjainak szintézisére
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
EP0161007A3 (de) Retro-inverso C-Terminal-Hexapeptid-Analoga von der Verbindung P
IL138658A0 (en) Chimeric protein
DK0427863T3 (da) DNA, som koder for protein, som kan kombinere med forstærker for alfa-fetoprotein-gen
NO20012232L (no) Enzymatisk amidering av peptider
DE69434151D1 (de) Therapeutische inhaltsstoffe
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
DE69832064D1 (de) Transporterproteine spezifisch für Schilddrüsenhormone und deren Agonisten und Antagonisten
ATE207217T1 (de) Verfahren zur vermittlung von transaktionsschritten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application